« Back
Home /
Nivolumab (anti-PD-1)

Nivolumab (anti-PD-1)

Item no.	A2002-25mg
Manufacturer	Selleckchem
CASRN	946414-94-4
Amount	1mg x 25
Quantity options	1mg 1mg x 25 1mg x 5
Category	Oncology Antibodies By Cell Type Carcinoma Hematology Lymphoma Myelofibrosis Primary Antibodies
Type	Antibody
Specific against	other
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	BMS-936558, ONO-4538, MDX-1106
Available
Storage Conditions	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Information	Nivolumab (anti-PD-1) is a genetically engineered, fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1, PCD-1) with immune checkpoint inhibitory and antineoplastic activities. MW : 143.597 KD.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1mg x 25

available

Delivery expected until 1/10/2025

Express Delivery: Save 2 days

Compare

Add to wishlist

Recommend by mail